96725 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Glycopegylation methods and proteins/peptides produced by the methods
#302POLYMER CONJUGATES OF BIPHALIN PEPTIDES
#303HCV protease inhibitors and uses thereof
#304Oligopeptides And Their Use In Cosmetics
#305Biologically active peptides and their new uses
#306Eye drops
#307BIOLOGICALLY PRODUCED CYCLIC AFFINITY TAGS
#308High penetration prodrug compositions of peptides and peptide-related compounds
#309Antineoplastic hydrogels, and enzyme-instructed preparations thereof
#310Oligopeptides and cosmetic compositions containing the oligopeptides
#311Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#312PEPTOID COMPOUNDS
#313Compounds for enzyme inhibition
#314Compounds for enzyme inhibition
#315Self-assembling peptides bearing organic electronic functionality and applications employing the same
#316Compounds for enzyme inhibition
#317Compounds for enzyme inhibition
#318Compounds for enzyme inhibition
#319Compounds for enzyme inhibition
#320Compounds for enzyme inhibition
#321Composition for improving brain function and method for improving brain function
#322Peptidomimetic protease inhibitors
#323Therapeutic and diagnostic conjugates for use with multispecific antibodies
#324Neuroprotective and neurorestorative method and compositions
#325Methods for preventing or treating mitochondrial permeability transition
#326G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#327Method of producing a novel opioid peptide
#328Peptidic compounds
#329Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#330Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#331APO-LIPOPROTEIN PROPEPTIDE
#332Organic compounds and their uses
#333FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#334PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#335Synthetic peptide amides and dimers thereof
#336Process for the production of bivalirudin
#337Michael systems as transglutaminase inhibitors
#338INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF
#339Uses of kappa opioid synthetic peptide amides
#340Detergent composition
#341Advantageous Salts of Mu-Opiate Receptor Peptides
#342Compositions containing interleukin-1 and peptides
#343Polyheterocyclic compounds highly potent as HCV inhibitors
#344T-cell death-inducing epitopes
#345Methods for treating colorectal cancer
#346Methods and compositions for preventing or treating ophthalmic conditions
#347Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C
#348Gamma amino acid building blocks
#349Synthetic peptide amides and dimeric forms thereof
#350Peptide biosynthesis and pain therapy
#351Peptide biosynthesis and pain therapy
#352Depsipeptides and their therapeutic use
#353Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#354Skin aging-inhibiting peptide
#355METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#356ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#357Methods for treating a skin wound
#358Molecular Interactions in Neurons
#359Stabilized liquid enzyme compositions
#360Tag peptide and use thereof
#361FLUOROGENIC PEPTIDES AND THEIR METHOD OF PRODUCTION
#362Blood coagulation factor inhibitors
#363Organic compounds and their uses
#364Compounds Binding to P-Selectin
#365Methods for reducing CD36 expression
#366METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#367Lipid peptide and hydrogel
#368Conformationally constrained peptide mimetics
#369Derivatised proline containing peptide compounds as protease inhibitors
#370PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#371PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#372Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
#373Method and carrier complexes for delivering molecules to cells
#374D-amino acid peptides
#375Mucin hypersecretion inhibitors and methods of use
#376METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#377Imaging probes
#378Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
#379Environmentally sensitive fluorophores
#380Smart Pro-Drugs of Serine Protease Inhibitors
#381PEPTOID COMPOUNDS
#382Compounds for enzyme inhibition
#383Compounds for enzyme inhibition
#384Peptidomimetic protease inhibitors
#385Oligopeptides and their use in cosmetics
#386COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
#387Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#388Template-fixed peptidomimetics
#389CARDIOPROTECTIVE COMPOUNDS
#390REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF
#391NOVEL SMALL MOLECULE DNAK INHIBITORS
#392Regulation of autophagy pathway phosphorylation and uses thereof
#393Uses of synthetic peptide amides
#394TARGETED PHOTODYNAMIC THERAPY AGENT
#395Hemiasterlin derivatives and uses thereof in the treatment of cancer
#396Substituted piperazin-2,5-diones and their use as multifunctional bioactive compounds
#397Glycopegylation methods and proteins/peptides produced by the methods
#398HCV protease inhibitors and uses thereof
#399N-Oxides of Kappa Receptor Peptides
#400Peptides directed for diagnosis and treatment of amyloid-associated diseases
#401PROCESS FOR DETECTING ENZYME ACTIVITY IN AN IMMUNOASSAY
#402Production and use of novel peptide-based agents with bispecific antibodies
#403Agents for the Detection and Modulation of B-Cells and Antibodies
#404High penetration prodrug compositions of peptides and peptide-related compounds
#405Methods of inhibiting osteoclast activity
#406Peptide turn mimetics
#407Mucin hypersecretion inhibitors and methods of use
#408Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
#409Synthetic peptide amide dimers
#410Methods for reducing CD36 expression
#411Selective substrates for matrix metalloproteinases
#412BIOLUMINESCENT CONSTRUCT
#413Methods for prevention and treatment of acute renal injury
#414Composition for palladium-mediated cleavage of peptides containing CXC, CXH or CHM sequences
#415PAR-2 agonist
#416COMPOUNDS FOR ENZYME INHIBITION
#417SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS
#418Method of screening for compounds that disaggregate amyloid aggregates
#419Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof
#420Difluorinated tripeptides as HCV serine protease inhibitors
#421Heteroaryl-containing tripeptide HCV serine protease inhibitors
#422Methods and compositions for the treatment of gastrointestinal disorders
#423Crystalline and amorphous forms of peptide
#424Synthetic peptide amides and dimeric forms thereof
#425Organic compounds and their uses
#426PAR-2 agonist
#427Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
#428Enzyme inhibition
#429Synthetic peptide amides
#430Oligopeptides and compositions containing the oligopeptides
#431METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
#432Methods and compositions for the treatment of gastrointestinal disorders
#433Compounds Binding To P-Selectin
#434Methods for the directed expansion of epitopes for use as antibody ligands
#435Methods for treating a corneal disorder and promoting skin wound healing
#436Antibody Binding Affinity Ligands
#437Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#438Peptidic compounds
#439Antibacterial amide macrocycles VI
#440Growth Hormone Secretagogue Receptor 1A Ligands
#441BIOLOGICALLY ACTIVE PEPTIDES
#442C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#443Compounds and methods for inhibiting apoptosis
#444Fluorous capping reagents and methods for peptide purification
#445ANTIBACTERIAL AMIDE-MACROCYCLES V
#446Convergent Solid Phase Peptide Synthesis By Reaction Of Two Fragments Bound To Solid Support
#447Growth hormone releasing peptides
#448Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)
#449Biologically active peptides and their new uses
#450PHARMACEUTICAL COMPOSITIONS OF HYDROMORPHONE FOR PREVENTION OF OVERDOSE OR ABUSE
#451Compounds for enzyme inhibition
#452Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity
#453Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#454Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
#455Therapeutic administration of the scrambled anti-angiogenic peptide C16Y
#456Antibacterial amide macrocycles IV
#457Hemiasterlin derivatives and uses thereof in the treatment of cancer
#458Peptide Derivative
#459Compounds for enzyme inhibition
#460Organic compounds and their uses
#461Biologically active peptide PTTKTYFPHF
#462Organic Compounds and Their Uses
#463Conjugates useful in the treatment of prostate cancer
#464Multi-location tractor trailer pneumatic connections
#465Biologically Active Peptides
#466Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
#467Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#468Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#469Compounds for enzyme inhibition
#470Cell death modulation via antagonists of Fasl and Fas activation
#471Beta secretase exosite binding peptides and methods for identifying beta secretase modulators
#472D-amino acid peptides
#473Peptides and methods using same for diagnosing and treating amyloid-associated diseases
#474Rapamycin peptides conjugates: synthesis and uses thereof
#475Conjugates useful in the treatment of prostate cancer
#476Methods for reducing CD36 expression
#477Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#478Peptoid compounds
#479Antibacterial macrocycles with substituted biphenyl
#480Histone H2A peptide derivatives and uses thereof
#481Antitumor agents
#482Orally administered small peptides synergize statin activity
#483Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#484Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#485Methods for preventing or treating ischemia-reperfusion injury of the kidney
#486Glycopegylation methods and proteins/peptides produced by the methods
#487Conjugates useful in the treatment of prostate cancer
#488Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#489Method of treating interferon non-responders using HCV protease inhibitor
#490Phex substrates and methods using same
#491Biologically active peptides
#492Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
#493Methods and compositions for the treatment of gastrointestinal disorders
#494Compounds for inhibiting cathepsin activity
#495Potent and specific immunoproteasome inhibitors
#496Compounds and their analgesic applications
#497Melanocortin Metallopeptode Combinatorial Libraries and Applications
#498Peptides directed for diagnosis and treatment of amyloid-associated disease
#499Method of designing physiologically active peptide and use thereof
#500Compounds binding to p-selectin
#501G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
#502Intracellular delivery of biological effectors
#503Mucin hypersecretion inhibitors and methods of use
#504Protein and its use in diagnosing Alzheimer's disease
#505Intracellular delivery of biological effectors
#506Biologically active peptide conjugates
#507Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#508Conjugates useful in the treatment of prostate cancer
#509Molecular interactions in neurons
#510Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#511Peptides and methods for the control of obesity
#512Melanocortin receptor ligands
#513Fluorogenic enzyme assay methods, kits and compositions using charge-balancers
#514Smart pro-drugs of serine protease inhibitors
#515Compounds for enzyme inhibition
#516Opioid metallopeptide compositions and methods
#517Low molecular weight peptidomimetic growth hormone secretagogues
#518Production and use of novel peptide-based agents with bispecific antibodies
#519Compounds for enzyme inhibition
#520Immunosuppressant compounds, methods and uses related thereto
#521T-cell death-inducing epitopes
#522Peptide amidation process
#523Molecular interactions in cells
#524Peptides and their use to ameliorate cell death
#525Binding moieties for fibrin
#526Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
#527Antitumor agents
#528Compounds for enzyme inhibition
#529Hemiasterlin derivatives and uses thereof
#530Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
#531Peptidomimetic protease inhibitors
#532Selective substrates for matrix metalloproteinases
#533Opioid metallopeptide compositions and methods
#534Orally administered small peptides synergize statin activity
#535Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#536Methods and compositions for derepression of IAP-inhibited caspase
#537Method and carrier complexes for delivering molecules to cells
#538Growth hormone releasing peptides
#539Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#540Methods and compositions for derepression of IAP-inhibited caspase
#541Methods of inhibiting osteoclast activity
#542Elastin peptide analogs and uses thereof
#543Elastin peptide analogs and uses thereof
#544Peptoid compounds
#545D-amino acid peptides
#546Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#547Peptide containing Ser-Ser-Ser-Arg
#548Therapeutic and diagnostic conjugates for use with multispecific antibodies